drug summary · 4 NDC codes
Cobenfy 50 mg/1; 20 mg/1
xanomeline and trospium chloride
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | xanomeline and trospium chloride |
|---|---|
| active ingredients | TROSPIUM CHLORIDE, XANOMELINE |
| dosage form | CAPSULE, COATED PELLETS |
| route | ORAL |
| strength | 50 mg/1; 20 mg/1 |
| marketing status | NDA |
| DEA schedule | not reported |
| application number | NDA216158 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | E.R. Squibb & Sons, L.L.C. |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Cholinergic Muscarinic Agonist [EPC]; Cholinergic Muscarinic Agonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA] |
NDC codes
4 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 00003005014 | — |
| 00003005060 | — |
| 00003005098 | — |
| 0003-0050 | — |
Other xanomeline and trospium chloride products
2 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- Cobenfy 100 mg/1; 20 mg/1CAPSULE, COATED PELLETS · E.R. Squibb & Sons, L.L.C.
- Cobenfy 125 mg/1; 30 mg/1CAPSULE, COATED PELLETS · E.R. Squibb & Sons, L.L.C.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.